Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2021-12-07 Sale | 2021-12-09 06:04 am | Day One Biopharmaceuticals Inc. | DAWN | TAKEDA PHARMACEUTICAL CO LTD Takeda Pharmaceuticals U.S.A. Inc. MILLENNIUM PHARMACEUTICALS INC Takeda Ventures Inc. 10% Owner | 297,273 | $18.49 | $5,496,869 | 6,120,124 (Indirect) | View |
| 2021-12-03 Sale | 2021-12-07 06:01 am | Day One Biopharmaceuticals Inc. | DAWN | TAKEDA PHARMACEUTICAL CO LTD Takeda Pharmaceuticals U.S.A. Inc. MILLENNIUM PHARMACEUTICALS INC Takeda Ventures Inc. 10% Owner | 110,209 | $18.1 | $1,994,530 | 6,417,397 (Indirect) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2022-07-01 Other | 2022-07-06 06:28 am | N/A N/A | Ovid Therapeutics Inc. | OVID | TAKEDA PHARMACEUTICAL CO LTD Takeda Pharmaceuticals U.S.A. Inc. 10% Owner | 5,752,500 | $0 | 19,033,246 (Indirect) | View |
| 2021-11-24 Other | 2021-11-29 5:16 pm | N/A N/A | Day One Biopharmaceuticals Inc. | DAWN | TAKEDA PHARMACEUTICAL CO LTD Takeda Pharmaceuticals U.S.A. Inc. MILLENNIUM PHARMACEUTICALS INC Takeda Ventures Inc. 10% Owner | 57,224 | $0 | 6,584,830 (Indirect) | View |
| 2019-05-13 Conversion | 2019-05-13 7:52 pm | N/A N/A | Cortexyme Inc. | CRTX | Takeda Ventures Inc. TAKEDA PHARMACEUTICAL CO LTD Takeda Pharmaceuticals International AG Takeda Pharmaceuticals U.S.A. Inc. 10% Owner | 5,359,604 | $0 | 2,679,802 (Direct) | View |
Ownership | 2019-05-08 6:51 pm | N/A N/A | Cortexyme Inc. | CRTX | Takeda Ventures Inc. TAKEDA PHARMACEUTICAL CO LTD Takeda Pharmaceuticals International AG Takeda Pharmaceuticals U.S.A. Inc. 10% Owner | 0 | $0 | 2,679,802 (Direct) | View |